Comparison

TTE Standard Views vs EBMRef

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

TTE Standard Views

This app aids in learning cardiac function assessment using transthoracic echocardiography. It provides interactive 3D models and TTE recordings for standard cardiology exam views, allowing users to visualize heart structures from any angle.

Highlights
  • Interactive 3D heart models
  • TTE recordings for standard views
  • Probe and ultrasound plane visualization
  • 3D model rotation
  • Rib cage removal option
  • Heart model orientation
Read full description

We have created this interactive application to assist with teaching and learning the assessment of cardiac function with transthoracic echocardiography (TTE). The primary challenge in learning TEE is translating the two dimensional echocardiographic image into a visualization of the three-dimensional (3D) structure of the heart. Users can view the TTE recordings for each of the 20 standard views used in a full cardiology exam and see the corresponding 3D model of the probe, ultrasound plane, heart and rib cage for that view. Each TTE view can be selected from a menu at the left of the screen, or by using arrow buttons to go to the next or previous view in the list. For each TTE view, the 3D model of the probe, ultrasound plane, heart and rib cage can be rotated in the horizontal or vertical plane to view it from any angle. The rib cage can be removed, the part of the heart above the echo plane can be removed, and the heart model can be oriented so the structures correspond to the TTE image.

About

EBMRef

Access summaries of landmark medical research across specialties. Quickly find key trial details like interventions, outcomes, and clinical relevance for bedside reference. Intended for educational use, it's a supplement to, not a replacement for, professional medical advice.

Highlights
  • Landmark research summaries
  • Organized by medical specialty
  • Key trial details (name, year, interventions, outcomes)
  • Clinical relevance distilled
  • Quick bedside access
  • Educational and informational
Features
Read full description

EBMRef provides summaries of landmark research across various medical specialties. Built for quick access at the bedside, it organizes pivotal trials by specialty and distills key details, including trial name, year, interventions, outcomes, and clinical relevance. As with all scientific literature, users should review the complete study to appreciate its methodology, potential biases, and limitations. This app is intended for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you may have regarding a medical condition, and never disregard or delay seeking professional advice because of information provided by this app. About Rishi Kumar, MD, FACC ("RK.MD") I'm an adult cardiothoracic anesthesiologist and cardiovascular ICU intensivist practicing in academic medicine. I'm passionate about teaching with free, open-access medical education. Learn more on my site: https://rk.md

Screenshots

EBMRef3 screens

Verdict

The call

The clearest difference is price: EBMRef at Free against TTE Standard Views's $4.99. EBMRef also leads on rating (5.0 vs 4.0) and review sentiment (100% vs 67%). TTE Standard Views's advantage is iOS requirement (6.0 vs 26.0). On ratings volume, ads, in-app purchases and device support there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

EBMRef is free to download; TTE Standard Views costs $4.99 up front. Neither carries in-app purchases, so what you see is what you pay.

ReceptionRating · Positive reviews · Number of ratings

EBMRef holds the better App Store score, 5.0 against 4.0. Both are backed by a comparable volume of ratings — 8 and 21 respectively. Written reviews point the same way: 67% of TTE Standard Views's written reviews are positive against 100% of EBMRef's.

UpkeepUpdate frequency

TTE Standard Views ships an update every 8 months, EBMRef every 3 weeks. The most recent releases landed on September 25, 2026 and September 23, 2026 respectively.

Scorecard6 real differences · 4 level
TTE Standard Views versus EBMRef: the parameters behind the verdict, then further details
ParameterTTE Standard ViewsEBMRef
Price$4.99Free — better
Rating4.0 (8 ratings)5.0 (21 ratings) — better
Positive reviews66.7% of reviews100.0% of reviews — better
Number of ratings821 — better
Update frequencyEvery 8 monthsEvery 3 weeks — better
AdsNoNo
In-app purchasesNoNo
MonetizationPaidFree — better
DevicesiPadiPhone, iPad — better
Requires iOS6.0 — better26.0
Further details — not scored
Size85 MB8 MB
Age rating4+17+
DeveloperUniversity Health NetworkRishi Kumar

Customer experience

TTE Standard Views

All ratings8 ratings
Positive75.0%
Neutral0.0%
Negative25.0%
Written reviews6 reviews
Positive66.7%
Neutral0.0%
Negative33.3%

EBMRef

All ratings21 ratings
Positive100.0%
Neutral0.0%
Negative0.0%
Written reviews1 reviews
Positive100.0%
Neutral0.0%
Negative0.0%

In-app purchases

None

TTE Standard Views

No in-app purchases

None

EBMRef

No in-app purchases

Questions

Is TTE Standard Views free?
TTE Standard Views costs $4.99, with no in-app purchases.
Is EBMRef free?
EBMRef is free to download, with no in-app purchases.
Which has better reviews, TTE Standard Views or EBMRef?
EBMRef is rated higher. TTE Standard Views averages 4.0 out of 5 from 8 ratings, while EBMRef averages 5.0 from 21 ratings.
Do TTE Standard Views or EBMRef have ads?
Neither TTE Standard Views nor EBMRef shows ads.
Which is updated more often, TTE Standard Views or EBMRef?
TTE Standard Views ships an update every 8 months, and EBMRef every 3 weeks. Most recently, TTE Standard Views was updated on September 25, 2026 and EBMRef on September 23, 2026.

Other comparisons